Organogenesis Inc. is a leading regenerative medicine company with the unique skill set to take complex, living therapies from research and development, through manufacturing, to successful commercialization to reach patients today. As a pioneer in the field of regenerative medicine, Organogenesis received the first FDA approval of a living, allogeneic, cell-based product Apligraf®, approved for the treatment of venous leg ulcers.
|Employees (est.) (Jan 2020)||785||(-1%)|
Organogenesis total Funding
Organogenesis latest funding size
Time since last funding
|3 years ago|
|Silicon Valley Bank, Eastward Capital Partners|
When was Organogenesis founded?
Organogenesis was founded in 1985.
Who are Organogenesis key executives?
Organogenesis's key executives are Gary S. Gillheeney, Timothy M. Cunningham and Brian Grow.
How many employees does Organogenesis have?
Organogenesis has 785 employees.
Who are Organogenesis competitors?
Competitors of Organogenesis include Arrowhead Pharmaceuticals, Capstone Therapeutics and TetraGenetics.
Where is Organogenesis headquarters?
Organogenesis headquarters is located at 85 Dan Rd, Canton.
Where are Organogenesis offices?
Organogenesis has offices in Canton, San Diego and Kanton Reinach.
How many offices does Organogenesis have?
Organogenesis has 4 offices.
Receive alerts for 300+ data fields across thousands of companies